| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operations Officer | SVP, Operations
1 company
Barclay Alec is a Chief Operations Officer at T2 Biosystems, Inc.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $182 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2022 | TTOO T2 Biosystems, Inc. | Chief Operations Officer | Buy | 12,952 | $0.50 | $6,475.94 | +7.7% | |
| Mar 17, 2021 | TTOO T2 Biosystems, Inc. | Chief Operations Officer | Sell | 12,494 | $1.86 | $23,238.84 | -14.4% | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | Chief Operations Officer | Sale+OE | 7,280 | $2.06 | $14,996.80 | -10.0% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | SVP, Operations | Sale+OE | 5,808 | $0.82 | $4,762.56 | -11.1% |